Fig. 4: Local immune response in BALFs and lungs in BALB/c mice immunized with rNA-N1-MPP vaccine adjuvanted with BDX100 or BDX301 adjuvants. | npj Vaccines

Fig. 4: Local immune response in BALFs and lungs in BALB/c mice immunized with rNA-N1-MPP vaccine adjuvanted with BDX100 or BDX301 adjuvants.

From: Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants

Fig. 4

a Percentage of memory B-cells and b activated B-cells in the lungs of vaccinated mice 10 days after the booster immunization (n = 5). c Level of IgA and IgG in the BALFs obtained from the immunized animals. Dots represent individual AUC values (n = 5); bars represent average values. d Flow cytometry plots showing the percentage of different B-cell subpopulations in the lungs of immunized mice (gated on live CD3‒CD19+CD38+GL7‒ cells). e Representative flow cytometry plots showing the percentage of tissue-resident memory T-cell subpopulations in the lungs of immunized mice (gated on live CD3+CD19‒CD4/CD8+ cells). Plots were produced by combining data from each separate sample into one file for each group (d, e). f–m CD4+ and CD8+ EM (CD44+CD62L‒), TRM (CD103+CD69+, CD103‒CD69+), and CD103+CD69‒ T-cell subpopulation percentage of the total number of CD4+ or CD8+ T-cells in the lungs of mice 10 days after the booster immunization (n = 5). Groups were compared using ANOVA followed by the Tukey posthoc test. P-values for the groups with statistically significant differences are shown on the plots.

Back to article page